Cancer-associated fibroblasts: multidimensional players in liver cancer

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Cancer-associated fibroblasts (CAFs) are abundant stromal cells influencing tumor growth via extracellular matrix (ECM) regulation.
• Previous attempts to target CAFs for cancer therapy have yielded controversial results.
• Recent advancements have uncovered diverse CAF subpopulations within the tumor microenvironment (TME).

Purpose of the Study:

• To review emerging Cancer-associated fibroblast (CAF) subclusters in hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).
• To detail the specific protein markers, signaling pathways, and functions of these CAF subpopulations.
• To highlight the importance of understanding CAF heterogeneity for therapeutic development.

Main Methods:

• Analysis of single-cell RNA sequencing (scRNAseq) data.
• Utilizing genetically engineered mouse models.
• Review of current literature on CAF subpopulations in liver cancer.

Main Results:

• Identification of diverse CAF subpopulations in the premalignant liver microenvironment (PME) of HCC and TME of ICC.
• Characterization of distinct protein markers and signaling pathways associated with specific CAF clusters.
• Demonstration of varied roles for different CAF subpopulations in cancer development.

Conclusions:

• CAF heterogeneity significantly impacts hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) progression.
• Understanding the specific functions and regulation of CAF subpopulations is crucial.
• Targeting distinct CAF subpopulations offers potential for developing novel liver cancer therapeutics.